My Size Inc

Aktienanalyse zu My Size Inc (MYSZ)

$0.762

-0.037 (-4.87%)Zum Schluss

Loading chart…
Hoch
0.790
Eröffnung
0.790
Volumengewichteter Durchschnittskurs
0.76
Volumen
21.32K
Marktkap.
2.46M
Tief
0.726
Umsatz
16.19K
EV/EBITDA, TTM
0.00

My Size Inc, formerly Knowledgetree Ventures Inc, is an Israel-based company that offers solutions for online consumers and retailers. Its solution, MySizeID, lets consumers create an online profile of their personal measurements, which can then be utilized with partnered online retailers to insure that no matter the manufacturer or size chart, they will get the right fit. For online retailers, MySizeID offers a solution that minimizes returns from online purchases. Its other products include: SizeUp, which allows users to measure flat surfaces through their smart phones; Cross-Site Search Feature, and In-Store Shopping Tool. The Company’s measurement technology serves a range of applications including the apparel, e-commerce do-it-yourself (DIY), shipping and parcel delivery industries.

mysizeid.com

KI-Analyse of My Size Inc (MYSZ)

Verkaufen

My Size Inc (MYSZ) is not a good buy right now due to its extremely low price and negative financial indicators. The current price is $0.80, which is 91.5% lower than its 52-week high of $9.76. Additionally, the stock has a very low RSI of 15.233, indicating it is oversold, but this is coupled with a concerning 19.05% decline over the past five days and a staggering 87.65% year-to-date drop. The main risk is the company's increasing net losses, which reached $1.48 million in Q1 2026, up from $1.06 million in Q1 2025, indicating ongoing financial struggles that may hinder recovery efforts.

Bewertungskennzahlen

Das aktuelle erwartete KGV von My Size Inc (MYSZ) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von -0.90.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
-0.90
Aktuelles P/E
0.00
Überbewertet
0.52
Unterbewertet
-2.31

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
-0.05
Aktuelles EV/EBITDA
0.00
Überbewertet
0.92
Unterbewertet
-1.02

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
1.04
Aktuelles P/S
0.00
Überbewertet
3.67
Unterbewertet
-1.59

Alphio-AI-Kursszenarien für MYSZ

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%MYSZ

$1.26

Szenariopreis

B

Basis

Basis · 50%MYSZ

$1.14

Szenariopreis

B

Bärisch

Bärisch · 25%MYSZ

$1.14

Szenariopreis

Event-Zeitleiste

2026-10-26 (ET)

16:30:00

My Size Files $100M Mixed Securities Shelf

2026-09-28 (ET)

17:00:00

Selling Stockholders Plan to Sell 4.02M Shares of Common Stock

2026-09-15 (ET)

20:30:00

MySize Issues 1,308,901 Shares at $1.91 Each

2026-08-12 (ET)

20:00:00

My Size Trading Halted, News Pending

2026-08-07 (ET)

12:00:00

Selling Stockholders Plan to Sell 26.02M Shares of Common Stock

News

MYSZ FAQ – beantwortet von Alphio AI

My Size Inc, formerly Knowledgetree Ventures Inc, is an Israel-based company that offers solutions for online consumers and retailers. Its solution, MySizeID, lets consumers create an online profile of their personal measurements, which can then be utilized with partnered online retailers to insure that no matter the manufacturer or size chart, they will get the right fit. For online retailers, MySizeID offers a solution that minimizes returns from online purchases. Its other products include: SizeUp, which allows users to measure flat surfaces through their smart phones; Cross-Site Search Feature, and In-Store Shopping Tool. The Company’s measurement technology serves a range of applications including the apparel, e-commerce do-it-yourself (DIY), shipping and parcel delivery industries. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

My Size Inc (MYSZ) is not a good buy right now due to its extremely low price and negative financial indicators. The current price is $0.80, which is 91.5% lower than its 52-week high of $9.76. Additionally, the stock has a very low RSI of 15.233, indicating it is oversold, but this is coupled with a concerning 19.05% decline over the past five days and a staggering 87.65% year-to-date drop. The main risk is the company's increasing net losses, which reached $1.48 million in Q1 2026, up from $1.06 million in Q1 2025, indicating ongoing financial struggles that may hinder recovery efforts.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln